Leadership
enosix Leadership
At enosix, you’ll find that we are guided by seasoned, experienced leaders who put clients first. Our goal is to simplify your technology connections to drive top-line, and bottom-line, growth. We believe that unified experiences create more opportunities–faster.
Nick has nearly three decades of senior executive experience in technology (B2B enterprise software & SaaS) at the VP, COO, President and CEO level, in addition to independent directorships. Nick’s experiences range from early stage to public companies. His leadership style exemplifies an agile approach that has yielded outstanding growth & quantifiable bottom-line outcomes in every position. In 2007 Nick sold enterprise group chat leader, Parlano, to Microsoft, now part of Microsoft Teams. Most recently, he served as Chief Executive Officer of Firm58, Inc. and Chief Operating Officer at Halo Investing.
Jeff Benson brings over 25 years of experience as a strategic sales leader within several hyper-growth technology companies across multiple industries and disciplines such as manufacturing, retail, financial services and regulated industries. He has built and managed teams for growth in start-ups and some very large fintechs over the last many years. Prior to joining enosix, he has held roles at FIS/Worldpay, Fiserv, KPMG and SunTrust Banks as well as a few start-ups – thoughtmill, Xpansion and S1. Jeff leverages his background in start-ups and larger fintechs alike to build dynamic and inclusive teams to create substantial growth and to better serve his customers.
Steve Hochheiser is a technology executive and dedicated leader with extensive experience directing global IT operations and implementing ERP systems at enterprise companies. He has a proven track record of success developing and executing IT strategies and partnerships designed to improve efficiency, increase sales revenue, and reduce costs.
Loren has over 25 years of experience as both a marketing and sales executive, holding senior level leadership positions with several disruptive, hypergrowth technology companies including QLIK, Onesource, FM Systems, Phononic and Netsertive, where she worked to raise their public profile through analyst and media relations, messaging, branding, and accelerated demand generation. Loren also serves as an advisory board member to St Jude Children’s Hospital and George Washington University’s School of Business. Loren is passionate about mentoring professional men and women into leadership positions and is a public speaker specializing in diversity and inclusion. She is originally from Chicago and holds a degree in Marketing Communications from the University of Wisconsin-Madison.
Scott Hickman has been with enosix for nearly seven years. As one of the initial employees, Scott has taken leadership of all financial and administrative functions of the organization, including the management of human resources. In his role, he manages the back-office systems and processes of enosix, including legal, compliance, accounting, and all administrative activities. Prior to joining enosix, Scott spent over five years on staff at accounting firm, Munninghoff, Lange & Company. In addition to maintaining an active Certified Public Accountant (CPA) license, Scott also holds BS degrees in both accounting and finance from Northern Kentucky University. As a current resident and native of the Northern Kentucky/Greater Cincinnati area, Scott is an avid fan of University of Kentucky sports, the Cincinnati Reds, and the Cincinnati Bengals.
enosix Board of Directors
We’re proud to have a Board of Directors who bring proven functional expertise across a range of technology-based industries.
John McIlwraith is a co-founder and managing director of Cincinnati-based
Allos Ventures (www.allosventures.com). Over the past 25 years he has led
investments in more than 25 information technology companies. He has
been an active member of the Midwest entrepreneurial ecosystem
community, beginning as an attorney with Jones Day in Cleveland, where he
co-founded the firm’s Private Ventures practice group and represented
Primus Venture Partners and Morgenthaler Ventures and several early-
stage technology companies.
Before founding Allos Ventures in 2010, John was a managing director of
Blue Chip Venture Company, and served as the senior vice president of
strategic planning and general counsel of Quantum Health Resources, a
publicly-traded healthcare services company that provided drugs and related
therapies to patients with rare chronic diseases.
John has been involved in a variety of startup ecosystem initiatives
throughout the Midwest including as a founding member of the Michigan
Venture Capital Association board of directors and as chairman of the board
of directors of OCEAN Accelerator. He is also the chairman of the board of
directors of publicly traded Meridian Bioscience.
John received a Bachelor of Arts degree from Hillsdale College in 1981 and a
Juris Doctor degree, magna cum laude, from Case Western Reserve
University School of Law in 1985.
Bill Trainor is a co-founder of both Mutual Capital Partners and Access Ventures Fund (2000). Bill leads the business to business practice for Mutual Capital Partners and has been an active angel investor since 1997. Until starting both venture funds, Bill was Senior Vice President-Head of E-Commerce Investment Banking at McDonald Investments, an investment bank acquired by Key Corp. At McDonald Investments, he focused on consumer, retail, healthcare, and service companies working closely with companies that were using technology to expand and complement their existing business structure. Bill joined McDonald Investments in 1994 after graduating from Columbia University with an A.B. in Political Science.
He serves on several non-profit boards; the Pennsylvania Venture Capital Association Board of Directors, founded in 1982 to catalyze venture investment and entrepreneurialism in Western Pennsylvania, and Flashes of Hope, an organization dedicated to creating powerful, uplifting portraits of children fighting cancer and other life-threatening illnesses as well as funding pediatric cancer research.
